Clock genes are a set of genes known to contribute to the regulation of the human body’s internal 24-hour cycle, also known as the circadian rhythm. One of these genes is the so-called CLOCK gene, […]
Measles cases in California and the United States are climbing to levels the country hasn’t seen in years.This article was originally published on MedicalXpress.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive muscle weakness. A research team at Tohoku University and Keio University has uncovered a unifying mechanism in ALS revolving around the expression of […]
In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how the disease transforms into its most lethal form and identified a promising new treatment strategy.This article was originally […]
YourChoice Therapeutics, working with Quotient Sciences and Incyte, reports that single oral doses of the investigational non‑hormonal male contraceptive YCT‑529 up to 180 mg produced no clinically relevant safety issues in 16 healthy men.This article […]
Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth assessment to date of how fast breast cancers grow in patients and how surgical delays […]
A potential target for experimental drugs that block PRMT5—a naturally occurring enzyme some tumors rely more on for survival—has been identified by researchers with the Fralin Biomedical Research Institute’s Cancer Research Center in Washington, D.C.This […]
Chronic kidney disease (CKD) appears to be associated with a higher risk of tooth loss, with a higher prevalence of CKD seen among individuals with fewer than 20 teeth, according to a study published online […]
An analysis of studies incorporating data from almost 30 million people has highlighted the role that air pollution—including that coming from car exhaust emissions—plays in increased risk of dementia.This article was originally published on MedicalXpress.com
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor (DPP4i) use, according to a study published online […]
© 2025 SimplyWell.ca